Clinical Trials · NCT03292185
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 24
- Start date
- Sep 2017
- Locations
- 1 site, China
- Primary endpoint
- Area under the serum insulin degludec concentration time curve